$UNH
UNITEDHEALTH GROUP INC

2016 Q1 Form 10-Q Financial Statement

#000073176616000068 Filed on May 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $44.53B $35.76B
YoY Change 24.53% 12.77%
Cost Of Revenue $5.877B $1.114B
YoY Change 427.56% 24.89%
Gross Profit $38.65B $34.64B
YoY Change 11.57% 12.42%
Gross Profit Margin 86.8% 96.88%
Selling, General & Admin $6.758B $5.834B
YoY Change 15.84% 12.32%
% of Gross Profit 17.49% 16.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $502.0M $378.0M
YoY Change 32.8% 5.0%
% of Gross Profit 1.3% 1.09%
Operating Expenses $6.758B $5.834B
YoY Change 15.84% 12.32%
Operating Profit $2.960B $2.640B
YoY Change 12.12% 28.53%
Interest Expense $259.0M $150.0M
YoY Change 72.67% -6.25%
% of Operating Profit 8.75% 5.68%
Other Income/Expense, Net
YoY Change
Pretax Income $2.701B $2.490B
YoY Change 8.47% 31.47%
Income Tax $1.074B $1.077B
% Of Pretax Income 39.76% 43.25%
Net Earnings $1.611B $1.413B
YoY Change 14.01% 28.57%
Net Earnings / Revenue 3.62% 3.95%
Basic Earnings Per Share $1.69 $1.48
Diluted Earnings Per Share $1.67 $1.46
COMMON SHARES
Basic Shares Outstanding 953.0M shares 954.0M shares
Diluted Shares Outstanding 967.0M shares 969.0M shares

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $10.60B $8.650B
Short-Term Investments
Other Short-Term Assets $3.211B $2.632B
YoY Change 22.0% 28.02%
Inventory
Prepaid Expenses
Receivables $7.777B $5.040B
Other Receivables $6.865B $5.346B
Total Short-Term Assets $33.75B $26.77B
YoY Change 26.04% 19.72%
LONG-TERM ASSETS
Property, Plant & Equipment $4.976B $4.245B
YoY Change 17.22% 4.43%
Goodwill $46.29B $32.78B
YoY Change 41.22% 1.97%
Intangibles $8.861B $3.441B
YoY Change 157.51% -11.02%
Long-Term Investments $23.31B $21.20B
YoY Change 9.99% -0.24%
Other Assets $3.084B $3.061B
YoY Change 0.75% 9.36%
Total Long-Term Assets $84.11B $62.95B
YoY Change 33.62% 1.1%
TOTAL ASSETS
Total Short-Term Assets $33.75B $26.77B
Total Long-Term Assets $84.11B $62.95B
Total Assets $117.9B $89.72B
YoY Change 31.36% 6.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.74B $10.52B
YoY Change 30.63% 14.83%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.702B $0.00
YoY Change
Long-Term Debt Due $6.504B $2.797B
YoY Change 132.53% 24.81%
Total Short-Term Liabilities $46.29B $34.98B
YoY Change 32.33% 13.88%
LONG-TERM LIABILITIES
Long-Term Debt $27.22B $15.58B
YoY Change 74.73% 7.25%
Other Long-Term Liabilities $1.887B $1.295B
YoY Change 45.71% 2.61%
Total Long-Term Liabilities $29.11B $16.87B
YoY Change 72.5% 6.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.29B $34.98B
Total Long-Term Liabilities $29.11B $16.87B
Total Liabilities $80.96B $56.39B
YoY Change 43.58% 10.99%
SHAREHOLDERS EQUITY
Retained Earnings $37.96B $34.15B
YoY Change 11.16% 3.14%
Common Stock $10.00M $10.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.17B $31.88B
YoY Change
Total Liabilities & Shareholders Equity $117.9B $89.72B
YoY Change 31.36% 6.02%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income $1.611B $1.413B
YoY Change 14.01% 28.57%
Depreciation, Depletion And Amortization $502.0M $378.0M
YoY Change 32.8% 5.0%
Cash From Operating Activities $2.318B $2.269B
YoY Change 2.16% 61.15%
INVESTING ACTIVITIES
Capital Expenditures $425.0M $373.0M
YoY Change 13.94% 5.67%
Acquisitions $1.697B $575.0M
YoY Change 195.13% 66.67%
Other Investing Activities -$14.00M $32.00M
YoY Change -143.75% -37.25%
Cash From Investing Activities -$4.181B -$1.525B
YoY Change 174.16% 152.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $302.0M $704.0M
YoY Change -57.1% 1.29%
Debt Paid & Issued, Net $601.0M $416.0M
YoY Change 44.47% 141.86%
Cash From Financing Activities $1.502B $496.0M
YoY Change 202.82% -186.56%
NET CHANGE
Cash From Operating Activities $2.318B $2.269B
Cash From Investing Activities -$4.181B -$1.525B
Cash From Financing Activities $1.502B $496.0M
Net Change In Cash -$361.0M $1.240B
YoY Change -129.11% 434.48%
FREE CASH FLOW
Cash From Operating Activities $2.318B $2.269B
Capital Expenditures $425.0M $373.0M
Free Cash Flow $1.893B $1.896B
YoY Change -0.16% 79.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000731766
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
950804129 shares
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
UNITEDHEALTH GROUP INC
CY2015Q4 unh Aarp Assets Under Management
AarpAssetsUnderManagement
2998000000 USD
CY2016Q1 unh Aarp Assets Under Management
AarpAssetsUnderManagement
2878000000 USD
CY2015Q4 unh Assets Measuredat Fair Valueona Recurring Basisasa Percentageof Total Assetsat Fair Value
AssetsMeasuredatFairValueonaRecurringBasisasaPercentageofTotalAssetsatFairValue
1.00
CY2016Q1 unh Assets Measuredat Fair Valueona Recurring Basisasa Percentageof Total Assetsat Fair Value
AssetsMeasuredatFairValueonaRecurringBasisasaPercentageofTotalAssetsatFairValue
1.00
CY2016Q1 unh Cumulative Effectof New Accounting Pronouncement
CumulativeEffectofNewAccountingPronouncement
28000000 USD
CY2015Q4 unh Investments Amortized Cost
InvestmentsAmortizedCost
20687000000 USD
CY2016Q1 unh Investments Amortized Cost
InvestmentsAmortizedCost
22995000000 USD
CY2015Q4 unh Investments Gross Unrealized Gains
InvestmentsGrossUnrealizedGains
268000000 USD
CY2016Q1 unh Investments Gross Unrealized Gains
InvestmentsGrossUnrealizedGains
414000000 USD
CY2015Q4 unh Investments Gross Unrealized Losses
InvestmentsGrossUnrealizedLosses
174000000 USD
CY2016Q1 unh Investments Gross Unrealized Losses
InvestmentsGrossUnrealizedLosses
93000000 USD
CY2015Q1 unh Supplemental Information For Prior Year Claimsand Claims Adjustment Expense
SupplementalInformationForPriorYearClaimsandClaimsAdjustmentExpense
140000000 USD
CY2016Q1 unh Supplemental Information For Prior Year Claimsand Claims Adjustment Expense
SupplementalInformationForPriorYearClaimsandClaimsAdjustmentExpense
360000000 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11994000000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13740000000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6523000000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7777000000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3334000000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2804000000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29000000 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000 shares
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000 shares
CY2015Q4 us-gaap Assets
Assets
111254000000 USD
CY2016Q1 us-gaap Assets
Assets
117855000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
31639000000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
33745000000 USD
CY2015Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
31286000000 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
33646000000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
209000000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
348000000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
117000000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
40000000 USD
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18539000000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20748000000 USD
CY2015Q4 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
58000000 USD
CY2016Q1 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
63000000 USD
CY2015Q4 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
57000000 USD
CY2016Q1 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
53000000 USD
CY2015Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
1638000000 USD
CY2016Q1 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
1739000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
4841000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
4968000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
7944000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
8019000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
1983000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
2046000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2534000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2539000000 USD
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18631000000 USD
CY2016Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
21056000000 USD
CY2015Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
1639000000 USD
CY2016Q1 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
1749000000 USD
CY2016Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
5000 positions
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7495000000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8650000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10923000000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10596000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10923000000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10596000000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1155000000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-327000000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.375
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.500
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
953000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
954000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
953000000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
954000000 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
10000000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
10000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
520000000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2141000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
520000000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2157000000 USD
CY2015Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1114000000 USD
CY2016Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5877000000 USD
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
33116000000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
41567000000 USD
CY2015Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
31972000000 USD
CY2016Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33586000000 USD
CY2015Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
33278000000 USD
CY2016Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
36137000000 USD
CY2015Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
31801000000 USD
CY2016Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
33552000000 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
122000000 USD
CY2016Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
145000000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2142000000 USD
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1901000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3587000000 USD
CY2016Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3066000000 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
378000000 USD
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
502000000 USD
CY2015Q1 us-gaap Dividends Cash
DividendsCash
357000000 USD
CY2016Q1 us-gaap Dividends Cash
DividendsCash
477000000 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.69
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.46
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-85000000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
34000000 USD
CY2015Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2016Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2015Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2016Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2015Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2016Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2015Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2016Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 USD
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 USD
CY2015Q4 us-gaap Goodwill
Goodwill
44453000000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
46294000000 USD
CY2015Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
510000000 USD
CY2016Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
508000000 USD
CY2015Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
1000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
3000000 USD
CY2015Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
0 USD
CY2016Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
0 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
114000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
114000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
186000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
184000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
83000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
82000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
128000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
128000000 USD
CY2015Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
511000000 USD
CY2016Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
511000000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2490000000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2701000000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1077000000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1648000000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1770000000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
758000000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1110000000 USD
CY2015Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
1049000000 USD
CY2016Q1 us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
1067000000 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-217000000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-251000000 USD
CY2015Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
1610000000 USD
CY2016Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
1368000000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2162000000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2162000000 USD
CY2015Q1 us-gaap Increase Decrease In Other Policyholder Funds
IncreaseDecreaseInOtherPolicyholderFunds
154000000 USD
CY2016Q1 us-gaap Increase Decrease In Other Policyholder Funds
IncreaseDecreaseInOtherPolicyholderFunds
266000000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8391000000 USD
CY2016Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8861000000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
150000000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
259000000 USD
CY2015Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
93000000 USD
CY2016Q1 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
245000000 USD
CY2015Q4 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
11000000 USD
CY2015Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
146000000 USD
CY2016Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
183000000 USD
CY2016Q1 us-gaap Investment Owned Balance Contracts
InvestmentOwnedBalanceContracts
26000
CY2015Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
20781000000 USD
CY2016Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
23316000000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
75793000000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
80964000000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111254000000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117855000000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42898000000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
46285000000 USD
CY2015Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
14330000000 USD
CY2016Q1 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
15823000000 USD
CY2015Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2496000000 USD
CY2016Q1 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
2508000000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6634000000 USD
CY2016Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6504000000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25331000000 USD
CY2016Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
27218000000 USD
CY2015Q4 us-gaap Long Term Investments
LongTermInvestments
18792000000 USD
CY2016Q1 us-gaap Long Term Investments
LongTermInvestments
20895000000 USD
CY2015Q4 us-gaap Minority Interest
MinorityInterest
-105000000 USD
CY2016Q1 us-gaap Minority Interest
MinorityInterest
-102000000 USD
CY2015Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
49000000 USD
CY2016Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
59000000 USD
CY2016Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
496000000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1502000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1525000000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4181000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2269000000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2318000000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
1413000000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
1611000000 USD
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2016Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16000000 USD
CY2015Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1413000000 USD
CY2016Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
1622000000 USD
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2640000000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2960000000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3118000000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3084000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-959000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
388000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-893000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
530000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
3000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
35000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
2000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
22000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
1000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
13000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
105000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
260000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
68000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
164000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
37000000 USD
CY2016Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
96000000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1481000000 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1887000000 USD
CY2015Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
44000000 USD
CY2016Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6000000 USD
CY2015Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
7798000000 USD
CY2016Q1 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
8317000000 USD
CY2015Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6801000000 USD
CY2016Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
6865000000 USD
CY2015Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
32000000 USD
CY2016Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-14000000 USD
CY2015Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
896000000 USD
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
500000000 USD
CY2015Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
357000000 USD
CY2016Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
477000000 USD
CY2015Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
575000000 USD
CY2016Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1697000000 USD
CY2015Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1891000000 USD
CY2016Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5173000000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
373000000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
425000000 USD
CY2015Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
25790000000 USD
CY2016Q1 us-gaap Policyholder Benefits And Claims Incurred Health Care
PolicyholderBenefitsAndClaimsIncurredHealthCare
28430000000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
31674000000 USD
CY2016Q1 us-gaap Premiums Earned Net
PremiumsEarnedNet
34811000000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2406000000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3211000000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
192000000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
198000000 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2485000000 USD
CY2015Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
843000000 USD
CY2016Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
978000000 USD
CY2015Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-270000000 USD
CY2016Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-385000000 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
1194000000 USD
CY2016Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-285000000 USD
CY2015Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
503000000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
2122000000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
1413000000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
1627000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4861000000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4976000000 USD
CY2015Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1736000000 USD
CY2016Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1824000000 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
416000000 USD
CY2016Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
601000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37125000000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37963000000 USD
CY2015Q1 us-gaap Revenues
Revenues
35756000000 USD
CY2016Q1 us-gaap Revenues
Revenues
44527000000 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1230000000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6393000000 USD
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2706000000 USD
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3140000000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5834000000 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6758000000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
125000000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
157000000 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
1988000000 USD
CY2016Q1 us-gaap Short Term Investments
ShortTermInvestments
2418000000 USD
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2016Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56000000 USD
CY2015Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
206000000 USD
CY2016Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
150000000 USD
CY2015Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
896000000 USD
CY2016Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
500000000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32454000000 USD
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31878000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
33725000000 USD
CY2016Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35067000000 USD
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15000000 shares
CY2016Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
969000000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
967000000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
954000000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
953000000 shares
CY2016Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of 2015, the Company aligned its accounting policy to conform the presentation of certain pharmacy fulfillment costs related to an acquired OptumRx business. These costs are now included in medical costs and cost of products sold, whereas they were previously included in operating costs. Prior periods have been reclassified to conform to the current period presentation. The reclassification increased medical expenses by </font><font style="font-family:inherit;font-size:10pt;">$101 million</font><font style="font-family:inherit;font-size:10pt;">, decreased operating costs by </font><font style="font-family:inherit;font-size:10pt;">$115 million</font><font style="font-family:inherit;font-size:10pt;"> and increased cost of products sold by </font><font style="font-family:inherit;font-size:10pt;">$14 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended March 31, 2015. The reclassification had no impact on total operating costs, earnings from operations, net earnings, earnings per share or total equity.</font></div></div>
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These Consolidated Financial Statements include certain amounts based on the Company&#8217;s best estimates and judgments. The Company&#8217;s most significant estimates relate to estimates and judgments for medical costs payable and revenues, valuation and impairment analysis of goodwill and other intangible assets and valuations of certain investments. Certain of these estimates require the application of complex assumptions and judgments, often because they involve matters that are inherently uncertain and will likely change in subsequent periods. The impact of any change in estimates is included in earnings in the period in which the estimate is adjusted.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accounting policies disclosed in Note 2 of Notes to the Consolidated Financial Statements in Part II, Item 8, &#8220;Financial Statements&#8221; in the 2015 10-K remain unchanged.</font></div></div>

Files In Submission

Name View Source Status
0000731766-16-000068-index-headers.html Edgar Link pending
0000731766-16-000068-index.html Edgar Link pending
0000731766-16-000068.txt Edgar Link pending
0000731766-16-000068-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uhglogo1a01a01a06.jpg Edgar Link pending
unh-20160331.xml Edgar Link completed
unh-20160331.xsd Edgar Link pending
unh-20160331_cal.xml Edgar Link unprocessable
unh-20160331_def.xml Edgar Link unprocessable
unh-20160331_lab.xml Edgar Link unprocessable
unh-20160331_pre.xml Edgar Link unprocessable
unh201633110-q.htm Edgar Link pending
unhex1213312016.htm Edgar Link pending
unhex3113312016.htm Edgar Link pending
unhex3213312016.htm Edgar Link pending